The physiology and clinical utility of anti-Müllerian hormone in women

Al-Inany "Gonadotrophin-releasing hormone antagonists for assisted reproductive technology" Cochrane Database Syst Rev (2011) 10.1002/14651858.cd001750.pub3

[3]

Al-Qahtani "Development of a sensitive enzyme immunoassay for anti-Mullerian hormone and the evaluation of potential clinical applications in males and females" Clin Endocrinol (Oxf) (2005) 10.1111/j.1365-2265.2005.02336.x

[4]

Almog "Age-related normograms of serum antimullerian hormone levels in a population of infertile women: a multicenter study" Fertil Steril (2011) 10.1016/j.fertnstert.2011.02.057

[5]

Andersen "Estradiol and regulation of anti-Mullerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles’ fluid" J Clin Endocrinol Metab (2006) 10.1210/jc.2006-1066

[6]

Andersen "Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Mullerian hormone and inhibin-B" Fertil Steril (2008) 10.1016/j.fertnstert.2007.05.003

[7]

Andersen "Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles" Hum Reprod (2010) 10.1093/humrep/deq019

[8]

Anderson "Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer" J Clin Endocrinol Metab (2011) 10.1210/jc.2010-2582

[9]

Anderson "Measuring anti-Mullerian hormone for the assessment of ovarian reserve: when and for whom is it indicated?" Maturitas (2012) 10.1016/j.maturitas.2011.11.008

[10]

Anderson "Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer" Eur J Cancer (2013) 10.1016/j.ejca.2013.07.014

[11]

Azziz "Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span" J Clin Endocrinol Metab (2005) 10.1210/jc.2005-0628

[12]

Azziz "The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report" Fertil Steril (2009) 10.1016/j.fertnstert.2008.06.035

[13]

Baarends "Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth" Endocrinology (1995) 10.1210/endo.136.11.7588229

[14]

Baird "Inhibin and related peptides in the regulation of reproduction" Oxford Rev Reprod Biol (1993)

[15]

Baker "Serum levels of mullerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay" J Clin Endocrinol Metab (1990) 10.1210/jcem-70-1-11

[16]

Balen "Ultrasound assessment of the polycystic ovary: international consensus definitions" Hum Reprod Update (2003) 10.1093/humupd/dmg044

[17]

Bath "Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound" Hum Reprod (2003) 10.1093/humrep/deg473

[18]

Behringer "Mullerian-inhibiting substance function during mammalian sexual development" Cell (1994) 10.1016/0092-8674(94)90251-8

[19]

Belville "Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model" Mol Endocrinol (2004) 10.1210/me.2003-0358

[20]

Bentzen "Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception" Reprod Biomed Online (2012) 10.1016/j.rbmo.2012.09.001

[21]

Bodri "Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study" Fertil Steril (2009) 10.1016/j.fertnstert.2007.11.049

[22]

Braat "Maternal death related to IVF in the Netherlands 1984–2008" Hum Reprod (2010) 10.1093/humrep/deq080

[23]

Braem "Interactions between genetic variants in AMH and AMHR2 may modify age at natural menopause" PloS one (2013) 10.1371/journal.pone.0059819

[24]

Broekmans "The antral follicle count: practical recommendations for better standardization" Fertil Steril (2010) 10.1016/j.fertnstert.2009.04.040

[25]

Broer "The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count" Fertil Steril (2009) 10.1016/j.fertnstert.2007.12.013

[26]

Broer "AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis" Hum Reprod Update (2011) 10.1093/humupd/dmq034

[27]

Broer "Anti-Mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women" J Clin Endocrinol Metab (2011) 10.1210/jc.2010-2776

[28]

Broer "Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach" Hum Reprod Update (2013) 10.1093/humupd/dms041

[29]

Brougham "Anti-Mullerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study" J Clin Endocrinol Metab (2012) 10.1210/jc.2011-3180

[30]

Caanen "Anti-mullerian hormone serum levels decrease in female to male transsexual women using testosterone as cross-sex therapy" Hum Reprod (2013)

[31]

Campbell "The role of anti-Mullerian hormone (AMH) during follicle development in a monovulatory species (sheep)" Endocrinology (2012) 10.1210/en.2012-1158

[32]

Carlsen "Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome" Hum Reprod (2009) 10.1093/humrep/dep074

[33]

Carlsson "Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro" Hum Reprod (2006) 10.1093/humrep/del165

[34]

Carre-Eusebe "Variants of the anti-Mullerian hormone gene in a compound heterozygote with the persistent Mullerian duct syndrome and his family" Hum Genet (1992) 10.1007/bf00220465

[35]

Cate "Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells" Cell (1986) 10.1016/0092-8674(86)90783-x

[36]

Catteau-Jonard "Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome" J Clin Endocrinol Metab (2007) 10.1210/jc.2007-0868

[37]

Catteau-Jonard "Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome" J Clin Endocrinol Metab (2008) 10.1210/jc.2008-1231

[38]

Catteau-Jonard "Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?" Ultrasound Obstet Gynecol (2012) 10.1002/uog.11202

[39]

Codner "Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus" J Clin Endocrinol Metab (2007) 10.1210/jc.2007-1252

[40]

Crisosto "Testosterone-induced downregulation of anti-Mullerian hormone expression in granulosa cells from small bovine follicles" Endocrine (2009) 10.1007/s12020-009-9227-6

[41]

Dafopoulos "Smoking and AMH levels in women with normal reproductive history" Arch Gynecol Obstet (2010) 10.1007/s00404-010-1425-1

[42]

Das "Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome" Hum Reprod (2008) 10.1093/humrep/den185

[43]

Decanter "Anti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results" Reprod Biomed Online (2010) 10.1016/j.rbmo.2009.11.010

[44]

Dewailly "Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Mullerian hormone concentrations aggregate with the markers of hyperandrogenism" J Clin Endocrinol Metab (2010) 10.1210/jc.2010-0334

[45]

Dewailly "Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries" Hum Reprod (2011) 10.1093/humrep/der297

[46]

di Clemente "A quantitative and interspecific test for biological activity of anti-mullerian hormone: the fetal ovary aromatase assay" Development (1992) 10.1242/dev.114.3.721

[47]

Dillon "Pretreatment antimullerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy" Fertil Steril (2013) 10.1016/j.fertnstert.2012.09.039

[48]

Dólleman "Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study" J Clin Endocrinol Metab (2013) 10.1210/jc.2012-3995

[49]

Durlinger "Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary" Endocrinology (1999) 10.1210/endo.140.12.7204

[50]

Durlinger "Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary" Endocrinology (2001) 10.1210/endo.142.11.8486

Showing 50 of 178 references

Cited By

810

Population-level analyses identify host and environmental variables influencing the vaginal microbiome

Lang Qin, Tianyong Sun · 2025

Signal Transduction and Targeted Th...

Ovarian stimulation by promoting basal follicular growth

Masao Jinno · 2025

Reproductive Biology and Endocrinol...

The LH:FSH Ratio in Functional Hypothalamic Amenorrhea: An Observational Study

Magdalena Boegl, Didier Dewailly · 2024

Journal of Clinical Medicine

Conditional loss of Brca1 in oocytes causes reduced litter size, ovarian reserve depletion and impaired oocyte in vitro maturation with advanced reproductive age in mice

Amy L. Winship, Lauren R. Alesi · 2024

EBioMedicine

Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis

Maeliss Peigné, Valérie Bernard · 2023

Human Reproduction

Role of anti mullerian hormone (AMH) in diagnosis of polycystic ovarian syndrome (PCOS) in Indian women

Neha Gupta, Uma Pandey · 2023

Indian Journal of Obstetrics and Gy...

Facilitation of Ovarian Response by Mechanical Force—Latest Insight on Fertility Improvement in Women with Poor Ovarian Response or Primary Ovarian Insufficiency

Chia Lin Chang · 2023

International Journal of Molecular...

Anti-Müllerian hormone and live birth in unexplained recurrent pregnancy loss

Sofie Bliddal, Ulla Feldt-Rasmussen · 2023

Reproductive BioMedicine Online

Making a good egg: human oocyte health, aging, and in vitro development

Evelyn E. Telfer, Johanne Grosbois · 2023

Physiological Reviews

Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis

A Haverinen, K Luiro · 2022

The Journal of Clinical Endocrinolo...

The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction

Qinying Xie, Yafei Kang · 2022

Frontiers in Endocrinology

Live Birth Rates in Women Under 38 Years Old with AMH Level < 1.2 ng/ml in the First In Vitro Fertilization + / − Intracytoplasmic Sperm Injection: Retrospective Study and Arguments for Care

Karine Morcel, Philippe Merviel · 2022

Reproductive Sciences

Anti-Müllerian Hormone in Female Reproduction

Nathalie di Clemente, Chrystèle Racine · 2021

Endocrine Reviews

Impact of Ovarian Yield—Number of Total and Mature Oocytes Per Antral Follicular Count—On Live Birth Occurrence After IVF Treatment

Marine Poulain, Rodine Younes · 2021

Frontiers in Medicine

Fertility and infertility: Definition and epidemiology

Mélodie Vander Borght, Christine Wyns · 2018

Clinical Biochemistry

Anti-Mullerian hormone and endometrial cancer: a multi-cohort study

Renée T Fortner, Helena Schock · 2017

British Journal of Cancer

Polycystic ovary syndrome (PCOS)

Adam H Balen · 2017

The Obstetrician & Gynaecologis...

Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates

J. Xu, C.V. Bishop · 2016

Human Reproduction

The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited

Robert L. Rosenfield, David A. Ehrmann · 2016

Endocrine Reviews

Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian hormone assays

Scott M. Nelson, Ewa Pastuszek · 2015

Fertility and Sterility

Metrics

810

Citations

178

References

Details

Published: Jan 14, 2014
Vol/Issue: 20(3)
Pages: 370-385

Authors

Cite This Article

Didier Dewailly, Claus Yding Andersen, Adam Balen, et al. (2014). The physiology and clinical utility of anti-Müllerian hormone in women. Human Reproduction Update, 20(3), 370-385. https://doi.org/10.1093/humupd/dmt062

The physiology and clinical utility of anti-Müllerian hormone in women

You May Also Like